-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
February 14, 2013
ImmunoGen, Inc. (IMGN) recently announced that it has finished enrolling patients for the initial stage of the ...
-
February 12, 2013
Recently, Celgene Corporation (CELG) announced that the US Food and Drug Administration (FDA) will review the ...
-
February 11, 2013
The US Food and Drug Administration (FDA) recently delivered encouraging news to Celgene Corporation (CELG) by ...
-
January 31, 2013
Pluristem Therapeutics, Inc. (PSTI) recently announced that it has taken possession of its new state-of-the-art ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 25, 2013
Investing in biotechnology can be exciting, profitable, and loaded with land mines. For every company that hits the ...
-
January 25, 2013
Celgene Corporation (CELG) recently announced that its oncology drug, Abraxane, has performed well in a phase III ...
-
January 24, 2013
Celgene Corporation's (CELG) fourth quarter 2012 earnings (excluding special items but including stock-based ...
-
January 18, 2013
InterMune Inc. (ITMN) recently priced its concurrent underwritten public offerings of convertible senior notes and ...
-
January 16, 2013
Pluristem Therapeutics, Inc. (PSTI) recently announced that the medical regulatory body for biological medicinal ...
-
January 16, 2013
InterMune Inc. (ITMN) recently announced its intention to raise funds through concurrent underwritten public ...
-
January 15, 2013
Shares of Celgene Corporation (CELG) hit a 52-week high of $97.71 almost at the end of the trading session on Jan ...
-
January 08, 2013
Celgene Corporation (CELG) recently provided an encouraging guidance for 2013. The biopharmaceutical company expects ...
-
January 07, 2013
Israel-based Pluristem Therapeutics, Inc. (PSTI) recently announced the initiation of the final validation steps for ...
-
January 02, 2013
The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed ...
-
December 19, 2012
Celgene Corporation (CELG) recently collaborated with Sutro Biopharma for the development of novel antibody drug ...
-
December 12, 2012
Bristol-Myers Squibb Company (BMY) and partner Abbott Laboratories (ABT) recently presented data on their oncology ...
-
December 10, 2012
On a good day for the market, the Nasdaq is trading up 0.6%, the S&P 500 is up 0.2% and the Dow has increased 0.3%. ...
